Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 106 entries
Sorted by: Best Match Show Resources per page
Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine.

Journal of chiropractic medicine

Martin BR, Seaman DR.
PMID: 26778934
J Chiropr Med. 2015 Sep;14(3):205-11. doi: 10.1016/j.jcm.2015.09.001. Epub 2015 Nov 11.

OBJECTIVE: The purpose of this case report is to describe the chiropractic management of a patient with atypical migraine headache.CLINICAL FEATURES: A 23-year-old woman experienced migraines for 3 months. She had no previous history of migraines and was unresponsive...

Cite
Martin BR, Seaman DR. Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine. J Chiropr Med. 2015;14(3):205-11doi: 10.1016/j.jcm.2015.09.001.
Martin, B. R., & Seaman, D. R. (2015). Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine. Journal of chiropractic medicine, 14(3), 205-11. https://doi.org/10.1016/j.jcm.2015.09.001
Martin, Brett R, and Seaman, David R. "Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine." Journal of chiropractic medicine vol. 14,3 (2015): 205-11. doi: https://doi.org/10.1016/j.jcm.2015.09.001
Martin BR, Seaman DR. Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine. J Chiropr Med. 2015 Sep;14(3):205-11. doi: 10.1016/j.jcm.2015.09.001. Epub 2015 Nov 11. PMID: 26778934; PMCID: PMC4685182.
Copy Download .nbib Format: NLM
Challenges in the delivery of therapies to melanoma brain metastases.

Current pharmacology reports

Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF.
PMID: 28546917
Curr Pharmacol Rep. 2016 Dec;2(6):309-325. doi: 10.1007/s40495-016-0072-z. Epub 2016 Nov 09.

Brain metastases are a major cause of morbidity and mortality in patients with advanced melanoma. Recent approval of several molecularly-targeted agents and biologics has brought hope to patients with this previously untreatable disease. However, patients with symptomatic melanoma brain...

Cite
Gampa G, Vaidhyanathan S, Resman BW, et al. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep. 2016;2(6):309-325doi: 10.1007/s40495-016-0072-z.
Gampa, G., Vaidhyanathan, S., Resman, B. W., Parrish, K. E., Markovic, S. N., Sarkaria, J. N., & Elmquist, W. F. (2016). Challenges in the delivery of therapies to melanoma brain metastases. Current pharmacology reports, 2(6), 309-325. https://doi.org/10.1007/s40495-016-0072-z
Gampa, Gautham, et al. "Challenges in the delivery of therapies to melanoma brain metastases." Current pharmacology reports vol. 2,6 (2016): 309-325. doi: https://doi.org/10.1007/s40495-016-0072-z
Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep. 2016 Dec;2(6):309-325. doi: 10.1007/s40495-016-0072-z. Epub 2016 Nov 09. PMID: 28546917; PMCID: PMC5440090.
Copy Download .nbib Format: NLM
Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction.

Haemophilia : the official journal of the World Federation of Hemophilia

Ragni MV, DiMichele DM, Hay CM, Malec LM, Seaman CD, Li J, Yabes JG, Butenas S, Brummel-Ziedins K.
PMID: 26517283
Haemophilia. 2016 Mar;22(2):240-247. doi: 10.1111/hae.12830. Epub 2015 Oct 30.

BACKGROUND: Inhibitor formation complicates haemophilia treatment and requires immune tolerance induction to rid inhibitors over 5 BU. In the prospective, randomized International Immune Tolerance Study, immune tolerance induction was equally effective with high-dose (HD) (200 IU kgMETHODS: We evaluated...

Cite
Ragni MV, DiMichele DM, Hay CM, et al. Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction. Haemophilia. 2015;22(2):240-247doi: 10.1111/hae.12830.
Ragni, M. V., DiMichele, D. M., Hay, C. M., Malec, L. M., Seaman, C. D., Li, J., Yabes, J. G., Butenas, S., & Brummel-Ziedins, K. (2016). Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction. Haemophilia : the official journal of the World Federation of Hemophilia, 22(2), 240-247. https://doi.org/10.1111/hae.12830
Ragni, M V, et al. "Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction." Haemophilia : the official journal of the World Federation of Hemophilia vol. 22,2 (2016): 240-247. doi: https://doi.org/10.1111/hae.12830
Ragni MV, DiMichele DM, Hay CM, Malec LM, Seaman CD, Li J, Yabes JG, Butenas S, Brummel-Ziedins K. Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction. Haemophilia. 2016 Mar;22(2):240-247. doi: 10.1111/hae.12830. Epub 2015 Oct 30. PMID: 26517283.
Copy Download .nbib Format: NLM
Immobilization of Uranium in Contaminated Sediments by Hydroxyapatite Addition.

Environmental science & technology

Arey JS, Seaman JC, Bertsch PM.
PMID: 26528590
Environ Sci Technol. 1999 Jan 15;33(2):337-42. doi: 10.1021/es980425+.

Batch equilibrations were performed to investigate the ability of hydroxyapatite (Ca5(PO4)3OH) to chemically immobilize U in two contaminated sediment samples having different organic carbon contents (123 and 49 g kg(-1), respectively). Apatite additions lowered aqueous U to near proposed...

Cite
Arey JS, Seaman JC, Bertsch PM. Immobilization of Uranium in Contaminated Sediments by Hydroxyapatite Addition. Environ Sci Technol. 1999;33(2):337-42doi: 10.1021/es980425+.
Arey, J. S., Seaman, J. C., & Bertsch, P. M. (1999). Immobilization of Uranium in Contaminated Sediments by Hydroxyapatite Addition. Environmental science & technology, 33(2), 337-42. https://doi.org/10.1021/es980425+
Arey, J S, et al. "Immobilization of Uranium in Contaminated Sediments by Hydroxyapatite Addition." Environmental science & technology vol. 33,2 (1999): 337-42. doi: https://doi.org/10.1021/es980425+
Arey JS, Seaman JC, Bertsch PM. Immobilization of Uranium in Contaminated Sediments by Hydroxyapatite Addition. Environ Sci Technol. 1999 Jan 15;33(2):337-42. doi: 10.1021/es980425+. PMID: 26528590.
Copy Download .nbib Format: NLM
Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours.

American journal of therapeutics

Cheung WK, Brunner L, Schoenfeld S, Knight R, Seaman J, Brox A, Batist G, John V, Chan K.
PMID: 11835092
Am J Ther. 1994 Oct;1(3):228-235. doi: 10.1097/00045391-199410000-00010.

The objective of this study was to determine the pharmacokinetics of pamidronate disodium in plasma and urine after a single intravenous infusion of the drug to cancer patients at risk for developing bone metastases. Thirty-six patients were randomized into...

Cite
Cheung WK, Brunner L, Schoenfeld S, et al. Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours. Am J Ther. 1994;1(3):228-235doi: 10.1097/00045391-199410000-00010.
Cheung, W. K., Brunner, L., Schoenfeld, S., Knight, R., Seaman, J., Brox, A., Batist, G., John, V., & Chan, K. (1994). Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours. American journal of therapeutics, 1(3), 228-235. https://doi.org/10.1097/00045391-199410000-00010
Cheung, W. K., et al. "Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours." American journal of therapeutics vol. 1,3 (1994): 228-235. doi: https://doi.org/10.1097/00045391-199410000-00010
Cheung WK, Brunner L, Schoenfeld S, Knight R, Seaman J, Brox A, Batist G, John V, Chan K. Pharmacokinetics of Pamidronate Disodium in Cancer Patients after a Single Intravenous Infusion of 30-, 60- or 90-mg Dose over 4 or 24 Hours. Am J Ther. 1994 Oct;1(3):228-235. doi: 10.1097/00045391-199410000-00010. PMID: 11835092.
Copy Download .nbib Format: NLM
Microarray analysis of nitric oxide responsive transcripts in Arabidopsis.

Plant biotechnology journal

Parani M, Rudrabhatla S, Myers R, Weirich H, Smith B, Leaman DW, Goldman SL.
PMID: 17134397
Plant Biotechnol J. 2004 Jul;2(4):359-66. doi: 10.1111/j.1467-7652.2004.00085.x.

Nitric oxide (NO) is emerging as an important signalling molecule with diverse physiological functions in plants. In the current study, changes in gene expression in response to 0.1 mm and 1.0 mm sodium nitroprusside (SNP), a donor of NO,...

Cite
Parani M, Rudrabhatla S, Myers R, et al. Microarray analysis of nitric oxide responsive transcripts in Arabidopsis. Plant Biotechnol J. 2004;2(4):359-66doi: 10.1111/j.1467-7652.2004.00085.x.
Parani, M., Rudrabhatla, S., Myers, R., Weirich, H., Smith, B., Leaman, D. W., & Goldman, S. L. (2004). Microarray analysis of nitric oxide responsive transcripts in Arabidopsis. Plant biotechnology journal, 2(4), 359-66. https://doi.org/10.1111/j.1467-7652.2004.00085.x
Parani, Madasamy, et al. "Microarray analysis of nitric oxide responsive transcripts in Arabidopsis." Plant biotechnology journal vol. 2,4 (2004): 359-66. doi: https://doi.org/10.1111/j.1467-7652.2004.00085.x
Parani M, Rudrabhatla S, Myers R, Weirich H, Smith B, Leaman DW, Goldman SL. Microarray analysis of nitric oxide responsive transcripts in Arabidopsis. Plant Biotechnol J. 2004 Jul;2(4):359-66. doi: 10.1111/j.1467-7652.2004.00085.x. PMID: 17134397.
Copy Download .nbib Format: NLM
Thrombotic events and markers of oxidation and inflammation in hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis

Schwing WD, Erhard P, Holloman CK, Weigel KA, Blankschaen SC, Anderson JM, Siegel CT, Seaman DS, Valente JF, Deoreo PB, Weiss MF.
PMID: 19379439
Hemodial Int. 2004 Oct 01;8(4):338-43. doi: 10.1111/j.1492-7535.2004.80407.x.

The goal of this study was to determine whether antioxidant therapy with vitamin E would alter the rate of vascular access complications or other macrovascular complications in hemodialysis (HD) patients. A secondary goal of the study was to explore...

Cite
Schwing WD, Erhard P, Holloman CK, et al. Thrombotic events and markers of oxidation and inflammation in hemodialysis. Hemodial Int. 2004;8(4):338-43doi: 10.1111/j.1492-7535.2004.80407.x.
Schwing, W. D., Erhard, P., Holloman, C. K., Weigel, K. A., Blankschaen, S. C., Anderson, J. M., Siegel, C. T., Seaman, D. S., Valente, J. F., Deoreo, P. B., & Weiss, M. F. (2004). Thrombotic events and markers of oxidation and inflammation in hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 8(4), 338-43. https://doi.org/10.1111/j.1492-7535.2004.80407.x
Schwing, William D, et al. "Thrombotic events and markers of oxidation and inflammation in hemodialysis." Hemodialysis international. International Symposium on Home Hemodialysis vol. 8,4 (2004): 338-43. doi: https://doi.org/10.1111/j.1492-7535.2004.80407.x
Schwing WD, Erhard P, Holloman CK, Weigel KA, Blankschaen SC, Anderson JM, Siegel CT, Seaman DS, Valente JF, Deoreo PB, Weiss MF. Thrombotic events and markers of oxidation and inflammation in hemodialysis. Hemodial Int. 2004 Oct 01;8(4):338-43. doi: 10.1111/j.1492-7535.2004.80407.x. PMID: 19379439.
Copy Download .nbib Format: NLM
Novel functional roles for PERIANTHIA and SEUSS during floral organ identity specification, floral meristem termination, and gynoecial development.

Frontiers in plant science

Wynn AN, Seaman AA, Jones AL, Franks RG.
PMID: 24778638
Front Plant Sci. 2014 Apr 07;5:130. doi: 10.3389/fpls.2014.00130. eCollection 2014.

The gynoecium is the female reproductive structure of angiosperm flowers. In Arabidopsis thaliana the gynoecium is composed of two carpels that are fused into a tube-like structure. As the gynoecial primordium arises from the floral meristem, a specialized meristematic...

Cite
Wynn AN, Seaman AA, Jones AL, et al. Novel functional roles for PERIANTHIA and SEUSS during floral organ identity specification, floral meristem termination, and gynoecial development. Front Plant Sci. 2014;5:130doi: 10.3389/fpls.2014.00130.
Wynn, A. N., Seaman, A. A., Jones, A. L., & Franks, R. G. (2014). Novel functional roles for PERIANTHIA and SEUSS during floral organ identity specification, floral meristem termination, and gynoecial development. Frontiers in plant science, 5130. https://doi.org/10.3389/fpls.2014.00130
Wynn, April N, et al. "Novel functional roles for PERIANTHIA and SEUSS during floral organ identity specification, floral meristem termination, and gynoecial development." Frontiers in plant science vol. 5 (2014): 130. doi: https://doi.org/10.3389/fpls.2014.00130
Wynn AN, Seaman AA, Jones AL, Franks RG. Novel functional roles for PERIANTHIA and SEUSS during floral organ identity specification, floral meristem termination, and gynoecial development. Front Plant Sci. 2014 Apr 07;5:130. doi: 10.3389/fpls.2014.00130. eCollection 2014. PMID: 24778638; PMCID: PMC3985007.
Copy Download .nbib Format: NLM
Recent progress in oligonucleotide therapeutics: antisense to aptamers.

Expert opinion on drug discovery

Leaman DW.
PMID: 23506176
Expert Opin Drug Discov. 2008 Sep;3(9):997-1009. doi: 10.1517/17460441.3.9.997.

BACKGROUND: Antisense and other RNA-targeting strategies have the potential to impact a broad array of human diseases. Although the methodological approaches for achieving targeted RNA degradation have changed over the past 5 - 10 years, the technological hurdles facing...

Cite
Leaman DW. Recent progress in oligonucleotide therapeutics: antisense to aptamers. Expert Opin Drug Discov. 2008;3(9):997-1009doi: 10.1517/17460441.3.9.997.
Leaman, D. W. (2008). Recent progress in oligonucleotide therapeutics: antisense to aptamers. Expert opinion on drug discovery, 3(9), 997-1009. https://doi.org/10.1517/17460441.3.9.997
Leaman, Douglas W. "Recent progress in oligonucleotide therapeutics: antisense to aptamers." Expert opinion on drug discovery vol. 3,9 (2008): 997-1009. doi: https://doi.org/10.1517/17460441.3.9.997
Leaman DW. Recent progress in oligonucleotide therapeutics: antisense to aptamers. Expert Opin Drug Discov. 2008 Sep;3(9):997-1009. doi: 10.1517/17460441.3.9.997. PMID: 23506176.
Copy Download .nbib Format: NLM
Utility of pulse oximetry in chiropractic practice?.

Journal of chiropractic medicine

Seaman DR.
PMID: 23843766
J Chiropr Med. 2012 Dec;11(4):310-1. doi: 10.1016/j.jcm.2012.09.001.

No abstract available.

Cite
Seaman DR. Utility of pulse oximetry in chiropractic practice?. J Chiropr Med. 2012;11(4):310-1doi: 10.1016/j.jcm.2012.09.001.
Seaman, D. R. (2012). Utility of pulse oximetry in chiropractic practice?. Journal of chiropractic medicine, 11(4), 310-1. https://doi.org/10.1016/j.jcm.2012.09.001
Seaman, David R. "Utility of pulse oximetry in chiropractic practice?." Journal of chiropractic medicine vol. 11,4 (2012): 310-1. doi: https://doi.org/10.1016/j.jcm.2012.09.001
Seaman DR. Utility of pulse oximetry in chiropractic practice?. J Chiropr Med. 2012 Dec;11(4):310-1. doi: 10.1016/j.jcm.2012.09.001. PMID: 23843766; PMCID: PMC3706705.
Copy Download .nbib Format: NLM
Neutron scattering studies of Y1-xUxPd3 compounds.

Physical review letters

Dai P, Koster JP, Maple MB, Mook HA, Seaman CL.
PMID: 10060231
Phys Rev Lett. 1995 Aug 07;75(6):1202-1205. doi: 10.1103/PhysRevLett.75.1202.

No abstract available.

Cite
Dai P, Koster JP, Maple MB, et al. Neutron scattering studies of Y1-xUxPd3 compounds. Phys Rev Lett. 1995;75(6):1202-1205doi: 10.1103/PhysRevLett.75.1202.
Dai, P., Koster, J. P., Maple, M. B., Mook, H. A., & Seaman, C. L. (1995). Neutron scattering studies of Y1-xUxPd3 compounds. Physical review letters, 75(6), 1202-1205. https://doi.org/10.1103/PhysRevLett.75.1202
Dai, et al. "Neutron scattering studies of Y1-xUxPd3 compounds." Physical review letters vol. 75,6 (1995): 1202-1205. doi: https://doi.org/10.1103/PhysRevLett.75.1202
Dai P, Koster JP, Maple MB, Mook HA, Seaman CL. Neutron scattering studies of Y1-xUxPd3 compounds. Phys Rev Lett. 1995 Aug 07;75(6):1202-1205. doi: 10.1103/PhysRevLett.75.1202. PMID: 10060231.
Copy Download .nbib Format: NLM
Superconductivity and magnetism in the Heusler alloys MPd2Pb (M=rare earth, Th, and U).

Physical review. B, Condensed matter

de Andrade MC, Dilley NR, Fisk Z, Herrmann J, Maple MB, Seaman CL.
PMID: 9983773
Phys Rev B Condens Matter. 1996 Feb 01;53(5):2651-2657. doi: 10.1103/physrevb.53.2651.

No abstract available.

Cite
de Andrade MC, Dilley NR, Fisk Z, et al. Superconductivity and magnetism in the Heusler alloys MPd2Pb (M=rare earth, Th, and U). Phys Rev B Condens Matter. 1996;53(5):2651-2657doi: 10.1103/physrevb.53.2651.
de Andrade MC, Dilley, N. R., Fisk, Z., Herrmann, J., Maple, M. B., & Seaman, C. L. (1996). Superconductivity and magnetism in the Heusler alloys MPd2Pb (M=rare earth, Th, and U). Physical review. B, Condensed matter, 53(5), 2651-2657. https://doi.org/10.1103/physrevb.53.2651
de Andrade MC, et al. "Superconductivity and magnetism in the Heusler alloys MPd2Pb (M=rare earth, Th, and U)." Physical review. B, Condensed matter vol. 53,5 (1996): 2651-2657. doi: https://doi.org/10.1103/physrevb.53.2651
de Andrade MC, Dilley NR, Fisk Z, Herrmann J, Maple MB, Seaman CL. Superconductivity and magnetism in the Heusler alloys MPd2Pb (M=rare earth, Th, and U). Phys Rev B Condens Matter. 1996 Feb 01;53(5):2651-2657. doi: 10.1103/physrevb.53.2651. PMID: 9983773.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 106 entries